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Multicomponent polysaccharide
alginate-based bioinks
Carmen C. Piras * and David K. Smith
3D-Bioprinting has seen a rapid expansion in the last few years, with an increasing number of reported
bioinks. Alginate is a natural biopolymer that forms hydrogels by ionic cross-linking with calcium ions.
Due to its biocompatibility and ease of gelation, it is an ideal ingredient for bioinks. This review focuses
on recent advances on bioink formulations based on the combination of alginate with other
polysaccharides. In particular, the molecular weight of the alginate and its loading level have an impact
on the material’s performance, as well as the loading of the divalent metal salt and its solubility, which
affects the cross-linking of the gel. Alginate is often combined with other polysaccharides that can
sigificantly modify the properties of the gel, and can optimise alginate for use in different biological
applications. It is also possible to combine alginate with sacrificial polymers, which can temporarily
reinforce the 3D printed construct, but then be removed at a later stage. Other additives can be
formulated into the gels to enhance performance, including nanomaterials that tune rheological
properties, peptides to encourage cell adhesion, or growth factors to direct stem cell differentiation. The
ease of formulating multiple components into alginate gels gives them considerable potential for further
development. In summary, this review will facilitate the identification of different alginate-polysaccharide
bioink formulations and their optimal applications, and help inform the design of second generation
bioinks, allowing this relatively simple gel system to achieve more sophisticated control over biological
processes.
Introduction
3D-Bioprinting is a rapidly expanding technology with much
promise in tissue engineering and regenerative medicine.1–6
This manufacturing technique is based on the 3D deposition
of biomaterials incorporating cells in desired layer-by-layer
patterns. A variety of applications has been reported for this
emerging technology including, amongst others, the produc-
tion of bone, cartilage and retina scaffolds, endothelial tissue
and vascular constructs, cardiac tissue and heart valves, and
skin regeneration.7–10
One of the most important factors for the successful fabrica-
tion of 3D printed scaffolds is the choice of the material to be
printed, or bioink. The bioink has to be suitable for the printing
technology adopted and has to display the right mechanical
properties (e.g. viscosity, stiffness, shear thinning behaviour) to
allow both the 3D deposition of the ink and stability of the
obtained constructs, but, more importantly, must be biocom-
patible to ensure cell survival during and after printing.11–13
Due to their chemical and physical properties, high water
content, biodegradability and capability to mimic the natural
environment of cells, hydrogels are ideal candidates as bioinks
for 3D bioprinting.12 These materials can incorporate more
than 99% water and can be obtained from cross-linked polymer
gelators (PGs) or via the self-assembly of low molecular weight
gelators (LMWGs) in aqueous media.14 So far, due to their
ease of gelation, simple manipulation and highly tuneable
mechanical properties, a wide variety of polymeric hydrogels
have been studied as bioinks. The majority of them are based
on natural molecules, such as collagen (ca. 26% of the reported
bioinks) and alginate (ca. 24%) or their composites with other
polymers.15 Further bioinks reported in literature are based on
other natural and synthetic polymers including hyaluronic acid,
gelatin, cellulose, soy protein, fibrinogen, chitosan, dextran,
starch, polylactic acid (PLA), poly(lactic-co-glycolic) acid (PLGA),
polyethylene glycol (PEG), polycaprolactone (PCL).15
Alginate is a natural polymer that can easily form hydrogels
by simple mixing with divalent cations. Being biocompatible
and very versatile, it is an ideal candidate for 3D bioprinting.
Since this field has seen a rapid expansion in the last few years,
the number of research articles on novel bioink formulations
is dramatically increasing. For this reason, when approaching
this research field, it can be difficult to acquire a clear idea of
the available formulations and their applications. This review
focuses on alginate-based bioinks prepared using pure alginate
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or in combination with other polysaccharides. The main goal is
to update the reader on the latest developments in this field,
providing a simple guide on available formulations, their
compositions and biological applications. We hope that this
article will simplify the identification of the main types of
alginate-based polysaccharidic bioinks and inform the design of
novel formulations. By developing a series of ‘design principles’
for bioprinted alginate gels, we hope that this review will facilitate
the development of new formulations with additional function-
ality and further promote uptake of these fascinating gel-phase
materials in high-tech applications.
Alginate-based bioinks and factors that
influence the properties of the 3D
printed structures
Alginate is a polysaccharide extracted from brown algae.
This biopolymer is composed of b-D-mannuronic acid and
a-L-glucuronic acid units linked through b(1–4) bonds (Fig. 1).16
The sodium salt of alginate is water-soluble and can readily
form hydrogels when mixed with multivalent cations (e.g. Ca2+,
Ba2+, Sr2+) by generating ionic inter-chain bridges.17 The ease
of gelation at room temperature, the mechanical properties, and
biocompatibility of sodium alginate make hydrogels of this poly-
mer great candidates as bioinks. A wide variety of alginate-based
inks has been reported and some of them are commercially
available (e.g. ‘CELLINK’).8,9,18,19
Overview of alginate 3D printing
One of the most advantageous features of alginate is its
versatility and applicability to a variety of scaffold fabrication
methods (e.g. spheroids, vascular constructs, microfluidic fibre-
shaped scaffolds)20–23 and bioprinting technologies (e.g. extrusion,
inkjet, and microfluidic bioprinting).24–27 Extrusion is probably the
most widely employed bioprinting methodology, employing the
controlled extrusion of long hydrogel filaments from a dispensing
cartridge.25 This technique can be applied with a variety of bioinks
ranging from low to high viscosities. Advantages of this methodo-
logy include scalability and cost-efficiency, but it has lower resolu-
tion compared to other methods. This review will mainly focus on
the different alginate/polysaccharide bioink formulations from a
biomaterial point of view rather than focus on printing technology.
Most of the examples we will discuss (unless specified) are based
on extrusion 3D printing, which is the most commonly used
technique for alginate/polysaccharide blends. We will explore in
detail the factors that can influence the printing process and the
properties of the 3D printed constructs obtained by extrusion.
However, because alginate is easy to gel at room temperature,
allowing the encapsulation of living cells before the printing
process, it can be readily applied to other bioprinting methods.
The reader is, therefore also referred to a number of additional
reviews and research articles for a more detailed discussion,24,26–34
and we will go on to briefly review inkjet and microfluidic
bioprinting technologies, for which the properties of this polymer
are particularly advantageous, later in this article.
Factors that influence the properties of the 3D printed
structures
Being a natural polymer, different types of sodium alginate are
commercially available, with different numbers of repeat units,
molecular weights and viscosities. All these factors, together
with the polymer concentration in aqueous solution, can
influence the features of the resulting hydrogels (e.g. porosity,
mechanical properties, shear-thinning behaviour, degradability)
and therefore the quality of the corresponding bioinks and their
compatibility with the growth of specific cell types (Fig. 2).8,35–39
All these elements should therefore be taken into consideration
when designing new bioinks.
More than 200 different alginates are currently being manu-
factured with molecular weights that can vary between 32 and
400 kDa, and a different content of b-D-mannuronic acid (M)
and a-L-glucuronic acid (G) units.40 Chen and co-workers
demonstrated that the molecular weight and the ratio between
the b-D-mannuronic acid (M) and a-L-glucuronic acid (G)
constituent units of sodium alginate can significantly influence
the rheological properties of the corresponding aqueous
solutions.41 Alginate chains of different molecular weight and
different M/G ratio and were obtained by acid hydrolysis and
separated by gel permeation chromatography. The viscosity
studies performed on aqueous solutions of the different
samples showed that the samples with lower molecular weight
and higher number of M units displayed a higher viscosity than
Fig. 1 Chemical structure of alginate.
Fig. 2 Schematic representation of 3D printing of alginate bioinks and
factors that can influence the properties of the bioink and the 3D printed
scaffolds.
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the samples with a higher molecular weight and a higher
number of G units.
The influence of alginate molecular weights and viscosities
on bioink performance was studied by the group of Kelly, who
performed a systematic study varying the ratio of alginate and
cross-linker.42 They showed that the molecular weight of
alginate influenced the viscosity of the resulting bioink and,
consequently, the amount of cross-linker required to obtain
stable 3D printed constructs. In particular, low molecular weight
alginate (28 kDa) resulted in less viscous bioinks that required
2.5 times more cross-linker than high molecular weight alginate
(75 kDa).
Another crucial factor that impacts 3D printability and
applicability of the resulting bioink is the alginate concentration.
Alblas and co-workers reported alginate-based bioink formula-
tions for gene therapy and osteogenic differentiation of embedded
cells, which displayed different printabilities depending on the
alginate concentration.43 The bioinks described in this study were
prepared using different alginate concentrations (1.0, 2.0, 3.0 and
4.0% wt/vol) and were combined with mesenchymal stem cells
(MSCs). The 3D constructs were cross-linked after the printing
process with a CaCl2 solution (100 mM). The different alginate
concentrations had an impact on bioink viscosity and scaffold
printability. Low alginate concentrations (o3.0% wt/vol) gave low
viscosity bioinks, which were not stable after printing. To over-
come this issue, a pre-printing cross-linking step with CaCl2
(25 mM) was introduced prior to extrusion. The different bioinks
incorporated a plasmid containing the gene encoding the bone
morphogenetic protein-2 (BMP-2), an osteogenic agent. Interest-
ingly, they displayed differences in transfection efficiency, which
were related to the polymer concentration. A low alginate concen-
tration (1.0% wt/vol) resulted in 40.8% transfection efficiency,
a 2.0% wt/vol concentration gave 35.7%, a 3.0% wt/vol concen-
tration gave 31.2% and 4.0% wt/vol resulted in only 11.8%
efficiency. Clearly as the gel network becomes increasingly dense,
the transfection efficiency of the plasmid is reduced, presumably
as a result of its diffusion within the gel network becoming
limited.
The alginate concentration in a bioink significantly affects
the physical properties of the formulation, which also influ-
ences cell viability, migration and proliferation. Mu¨ller and
co-workers studied this using four different alginate concentra-
tions (0.8%, 1.3%, 1.8% and 2.3% wt/vol) in combination with
gelatin.44 The resulting bioinks were used to 3D print MSCs
scaffolds, which were cross-linked with a 2% CaCl2 solution.
The obtained constructs displayed similar porosities (500–600 mm
pores), but different mechanical properties depending on the
alginate concentration, with compressive moduli ranging from
1.5 kPa (0.8% wt/vol) to 14.2 kPa (2.3% wt/vol). The constructs
prepared with higher alginate concentrations showed better
stability over time. However, those with the lowest alginate
concentration (0.8% wt) showed higher cell viability after 14 days.
The cells embedded in such scaffolds formed 3D interconnected
networks, whereas they formed spheroids when embedded in
bioinks that contained a higher alginate concentration. This
suggests that, as might be expected, within a softer gel, cells are
better able to exert a mechanical influence on the gel network
and hence establish their own networks.
Further research on the influence of alginate concentration on
cell behaviour, was carried out by the group of Xu, who studied
the effect on cell sedimentation and local concentration.45 During
the printing process the cells embedded in a bioinkmay sediment
or aggregate over time, leading to inhomogeneous cell distribu-
tion through the 3D scaffold. The researchers, therefore, tested
the effect of different alginate concentrations (0.5–4.0% wt/vol)
and different standing times (0–120 min) on the homogeneity
of 3D scaffolds of fibroblasts. They observed that the cell sedi-
mentation velocity decreased at higher alginate concentrations.
This induced a better cell distribution within the bioink over time.
By contrast, the inks containing less alginate showed a non-
uniform cell distribution and the formation of aggregates due
to faster sedimentation. This clearly demonstrates that the poly-
mer concentration has to be carefully chosen to achieve optimal
mechanical properties for cell growth and distribution within the
printed scaffold.
Another factor that influences the physical properties of
the 3D printed constructs and their applicability is the type,
concentration and volume of cross-linker. The majority of
alginate hydrogels are obtained by cross-linking with calcium
ions, which can come from different sources (e.g. CaCl2, CaCO3,
CaSO4).
46 CaCl2 is a water-soluble salt; therefore, when an
aqueous solution of CaCl2 is combined with sodium alginate,
the Ca2+ ions are immediately available to form ionic inter-chain
bridges between the polymer chains.17 In this case, gelation
happens very quickly and the resulting gels can be inhomo-
geneous. By contrast, CaCO3 and CaSO4 are not water soluble,
but can release calcium ions in an acidic aqueous environment.
This process happens more slowly and, for this reason, the
hydrogels obtained using these salts as calcium sources, are more
homogeneous.46
The effect of different calcium ion sources (CaCl2, CaCO3
and CaSO4) on the printability window of different molecular
weight alginates was studied by Kelly and co-workers, who
performed a systematic study varying the ratio of alginate and
cross-linker.42 They demonstrated that the source of Ca2+ ions
has an impact on the mechanical properties of the constructs.
The 3D printed shapes cross-linked with CaSO4 were stiffer than
those formed using the other two cross-linkers. This difference in
mechanical properties was explained considering the different
solubility in water of the different cross-linkers and the rates of
gelation as described above. The lower solubility of CaSO4 results
in slower, more uniform gelation, which improves the mechanical
properties of the resulting gel. Interestingly, the stiffness of the
printed cylindrical constructs was spatially controlled from the
core to the periphery to direct the differentiation of encapsulated
MSCs. This was achieved by printing gradient constructs, where
the core of the construct was printed using the soft bioink and the
external part was printed with the stiff bioink. Stiffer regions
preferentially supported osteogenesis, whereas softer regions were
more suitable for adipogenesis.
Chen and co-workers described the effect of gelation time
and cross-linker volume on the mechanical properties of the
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resulting 3D printed alginate scaffolds.47 This study was per-
formed by varying the gelation time between 0 and 24 hours,
using different volumes of a 50 mM CaCl2 solution (1–5 mL). The
results showed that a larger volume of cross-linking agent (3 mL
vs. 1 mL) induced better mechanical stability immediately after
printing. However, a further volume increase (5 mL) did not
significantly improve the elastic modulus of the constructs after
24 hours from printing. Further studies on the effect of different
cross-linker concentrations on the mechanical properties of the
bioprinted structures were carried out by the group of Shu.48 The
gels (8.0% wt/vol alginate) were pre-cross-linked for 10 min with
different CaCl2 concentrations (50–300mM) and then treated with
a 60 mM solution of BaCl2. The elastic modulus (G
0) increased
progressively with increasing concentrations of CaCl2. In particular,
the G0 of the gels cross-linked with a 50 mM solution of CaCl2 was
around 5.2 kPa. This increased to ca. 20–21 kPa when exposed to
100 or 200 mM CaCl2 and to ca. 28 kPa when the cross-linker
concentration was 300 mM.48 The second cross-linking step was
decisive to improve the stability of the final constructs and to create
rigidity to withstand their shape during the printing process. These
bioinks incorporated human glioma cells, which showed 88%
viability after 11 days of culture.
All these studies demonstrate the importance of the type
and concentration of both alginate and cross-linker on the
properties and applicability of the derived bioinks as sum-
marised in Fig. 2. These factors are critical not only to define
the physical properties of the resulting bioink, but also the
degradability of the material, which is crucial in tissue engi-
neering applications.
Alginate degradation normally happens by the activity of
the enzyme alginate lyase, which can only be found in algae,
marine invertebrates and microorganisms.49 Due to the lack of
such enzymes into the human body, the in vivo degradation of
alginate scaffolds mainly depends on the activity of calcium
chelating agents (e.g. phosphates, citrates and lactates).50 The
degradation of alginate in phosphate buffer saline solution
(PBS), for example, was studied by Gao and coworkers.51 They
explored the swelling ratio, degradation time and the release of
the model protein bovine serum albumin (BSA) from calcium
alginate hydrogels prepared using different alginate concen-
trations (1.25–5.0% wt/vol). All the gels were stable in PBS for
the first three days and started to degrade after this time.
As might be expected, the gels prepared with the lowest
alginate concentration (1.25% wt/vol) were degraded faster
(28 days) than those obtained using higher polymer concen-
trations (2.5 and 5.0% wt/vol), which were still almost intact
after 56 days. The BSA release was remarkably influenced by
the gel degradation rate and it was faster for the gels that were
degraded more rapidly.
In general, the degradation of alginate can be quite slow and
unpredictable, but it is influenced by the properties of the
polymer.8 The example described above showed how alginate
concentration influences this process. However, other factors
should also be taken into consideration, such as molecular
weight and viscosity. Hydrogels from low molecular weight and
low viscosity alginate will be degraded more easily and rapidly
than materials obtained from high molecular weight and high
viscosity alginate.8,50,52 This was demonstrated, for example, by
Mooney et al., who studied the stiffness and degradation rate
of alginate hydrogels formed by combining ionically and
covalently cross-linked partially oxidized (1% uronic acid residues),
low molecular weight (B60 kDa) and high molecular weight
alginates (B120 kDa). All the hydrogels were prepared using a
2.0–3.0% wt/vol concentration of the different types of alginate
in different ratios and were cross-linked with CaSO4. Hydrogels
containing a higher ratio of lowmolecular weight alginates, showed
similar elastic moduli to those obtained from high molecular
weight alginates, but were degraded more rapidly as a result of a
faster separation between cross-linked domains over time.
Therefore, the choice of the type of alginate not only impacts
the range of suitable applications for a bioink, but also its
degradability. It is vitally important to keep this in mind when
designing materials for in vivo applications. In this case, it is
also important to consider that the degradation rate may differ
depending on the in vivo location of an implant. The group of
Patsenker monitored the degradation of fluorescently-labelled
alginate gels (0.5–1.5% wt/vol), cross-linked with calcium
gluconate (10.0% wt/vol), in vitro and after implantation in
rat hip and myocardium.53 By using viscosity-sensitive fluores-
cent dyes, they were able to demonstrate that denser implants
prepared with a higher alginate concentration were stable for a
longer time. Moreover, they observed that the half-life of the
hip implants (4 days) was shorter than the half-life of the
myocardium implants, which was of 6–8 days.
Different strategies can be applied to tune the degradability
of a bioink, such as modification of the molecular weight
distribution of alginate by application of gamma rays,37,52 or
chemical modification of the polymer structure by oxidation.54,55
Studies on the degradability of oxidised alginate-based bioinks
were carried out by the group of Mei, who prepared a library of
thirty inks using different oxidation percentages and concentra-
tions of alginate.19 The oxidative chemical modification was
carried out using sodium periodate to give alginate dialdehyde
derivatives with different percentages of oxidation. Interestingly,
variations in the alginate concentration (2, 5, 8, 15 and
20% wt/vol) and percentage of oxidation (0, 5, 10 and 15%)
had a remarkable influence on the viscosity of the resulting
bioinks, which was higher at higher alginate concentrations and
lower degrees of oxidation. The percentage of oxidation also
influenced the biodegradability of the 3D printed scaffolds,
which were classified as poorly degradable (0% oxidation),
moderately degradable (5% oxidation) and highly degradable
(10 and 15% oxidation). The viscosity and density of the
obtained bioinks and the influence of these factors on print-
ability were systematically investigated using adipose-derived
stem cells (hADSCs). All the developed hydrogels showed the
capability to modulate cell proliferation and spreading, without
affecting the structural integrity of the 3D printed structures
after 8 days. However, the gels with a higher percentage of
oxidation showed higher percentages of cell proliferation after
8 days of culture (173% for the non-oxidised gels and 232–248%
for the 5–15% oxidised gels respectively).
Review Journal of Materials Chemistry B
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
0 
A
ug
us
t 2
02
0.
 D
ow
nl
oa
de
d 
on
 8
/1
8/
20
20
 1
0:
24
:0
1 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
This journal is©The Royal Society of Chemistry 2020 J. Mater. Chem. B
Other fabrication technologies for alginate 3D bioprinting
Inkjet printing technology is based on the ejection of high-
resolution bioink droplets through a nozzle.25 This process can
be induced by a piezoelectric transducer or a heater and
requires low viscosity bioinks. Although nozzle clogging can
represent an issue, this system allows rapid, cost-effective,
high-resolution bioprinting of highly reproducible micro-
droplets or microcapsules by direct deposition of sodium
alginate droplets into a cross-linker solution.56 The size and
the shape of the printed droplets can be controlled by varying the
cross-linker concentration and viscosity as well as the printing
parameters. For example, the group of Sˇteˇpa´nek described
the preparation of alginate microbeads (0.5–1.0% wt/vol) with a
50–70 mm diameter using a piezoelectric inkjet device.57 The
droplets were released into magnetically stirred CaCl2 solutions
(2.0% wt/vol) with variable viscosities (1–100 mPa), obtained by
addition of different glycerol concentrations (0–82% wt/vol). The
droplet size was controlled by modifying the voltage applied to
drive the piezoelectric print-head. Interestingly, the cross-linker
viscosity remarkably influenced the shape of the resulting
particles. Low viscosity cross-linker solutions gave elongated
microbeads, which became spherical or flattened for medium
and high viscosity solutions respectively reflecting the more
heavily crosslinked structures.
The influence of cross-linker concentration on the size of 3D
printed microspheres was studied by O’Leary and co-workers,
who prepared alginate microcapsules (0.5% wt/vol) for the
release of the model drug dextran–fluorescein isothiocyanate
(dextran–FITC) using an inkjet piezoelectric printing system.58
The concentration of the CaCl2 cross-linker bath was varied
between 1.0 and 5.0% wt/vol. The microspheres obtained from
the lowest cross-linker concentration (1.0% wt/vol) had a larger
diameter (c.a. 38 mm) than the diameter of the particles
obtained at the highest CaCl2 concentration (c.a. 12 mm), which
were also more spherical and more consistent in size.
The influence of the type of inkjet technology on the resulting
3D printed alginate microbeads was studied by Schubert’s group,
who compared two different inkjet systems: a drop-on-demand
and a continuous ink release technology.59 Both methods allowed
the preparation of highly reproducible sub-nanolitre droplets, but
displayed very significant differences in terms of the sizes of the
generated beads. This comparative study was carried out using a
1.0% wt/vol alginate concentration loaded with the dye brilliant
blue G to provide contrast, which was added dropwise to a 15.0%
wt/vol CaCl2 bath. The beads obtained using the drop-on-demand
printing technology showed a tear-drop shape with an average
diameter of 48 mm. By contrast, the continuous inkjet system
produced much larger beads with an average diameter of 248 mm.
Another bioprinting technology that can be applied to
alginate-based bioinks is microfluidic bioprinting, which is based
on the precise flow of small amounts of fluids (109 to 1018 L
volumes) throughmicrochannels.26 This technique allows the fabri-
cation of high resolution 3Dprintedmicrofibers ormicrobeadswith
efficient control of bothmorphology and dimensions.26Noteworthy
applicationsofmicrofluidic technology include theproductionof3D
printed vascular structures and cellular organoids.27,60,61
As described above for the inkjet technique, in this case, the
concentration of alginate and of the cross-linker once again has
a remarkable effect on the features of the bioprinted structures.
Aguilera and co-workers studied the effects of these two factors
on the mechanical properties of calcium alginate fibres pre-
pared using a microfluidic device.62 The fibres were obtained
by introducing a CaCl2 solution (0.5–2.5%) and an alginate
solution (1.25–2.5% wt/vol) into a microdevice. The flow rate
was controlled by two digital syringe pumps that created a
vertical laminar flow, which pushed downward the calcium
alginate fibres that were finally extruded into a CaCl2 bath. The
isolated fibres had a diameter of 300–550 mm and displayed
better tensile strength and elasticity at higher alginate and
cross-linker concentrations.
Juncker and co-workers studied the influence of printing
parameters, such as flow rate, on fibre size and morphology.63
The 3D printed microfibers (70–90 mm diameter) were prepared
using a 1.0 or 2.0% wt/vol alginate concentration, which was
combined with a 2.0% wt/vol CaCl2 solution before extrusion.
The flow rate remarkably influenced the shape of the fibers
and, to avoid curling or bulging, an optimal flow rate of 0.25–
0.5 mL min1 had to be applied. The rigidity of the 3D printed
constructs largely depended on the alginate concentration and,
as expected, it was higher when the highest concentration
(2.0% wt/vol) was used.
The use of microfluidic bioprinting to fabricate alginate
microspheroidal organoids was explored, amongst others, by
the group of He.64 The researchers prepared small spheroids
with average diameters of 1200–1400 mm by extruding a cell-
laden alginate solution (2.0% wt/vol) into a CaCl2 bath (2.0%
wt/vol). During extrusion, a gentle airflow was applied under
spinning, which modified the droplet microarchitecture to
obtain specific patterns such as a spiral, a rose or a saddle.
This technique was applied to obtain a human multicellular
organoid of spirally vascularised ossification.
All these 3D bioprinting techniques require bioinks with a
suitable viscosity and shear-thinning behaviour. The viscosity
of alginate bioinks can be easily tuned by modifying the
molecular weight and the concentration of the polymer, thus
making it easily adaptable.8 Moreover, differently from other
polymers (e.g. thermally triggered polymer gelators), alginate
allows cell encapsulation before printing and ensures cell
survival during and after printing.25 All these properties make
this material very versatile and suitable for use with different
3D printing technologies.
Applications of alginate-based bioinks
Due to their versatility and the possibility to tailor their
mechanical properties as described above, alginate bioinks
can be used to print a wide variety of cell types, including stem
cells, fibroblasts, neurons and hepatocytes. Given the ease by
which alginate systems can be fabricated, they have often been
combined with other additives in order to have an impact on
cell growth and behaviour.
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Mesenchymal stem cells, bone and cartilage scaffolds
Alginate bioinks have been proven to support mesenchymal
stem cells growth and differentiation, with better results when
prepared in combination with particles such as graphene oxide
or hydroxyapatite. Lee and co-workers reported an alginate
bioink formulation prepared with a 3% wt/vol alginate concen-
tration, which could be used to print 3D MSCs scaffolds.65 The
addition of graphene oxide (0.05–1.0 mg mL1) significantly
enhanced the capability of the cells to undergo osteogenic
differentiation, probably due to increased mechanical stiffness
of the gels. The authors tried to explain this osteoinductive
behaviour, by suggesting that the graphene oxide could help to
support the scaffold integrity and provide mechanical cues to
MSCs for osteogenesis. The best results in terms of printability
and stability of the 3D printed structures were obtained with
the lowest graphene oxide concentration (0.05 mg mL1). This
bioink formulation also showed the highest calcium deposition,
alkaline phosphatase activity and the highest expression of osteo-
genic markers, and was therefore considered the most suitable for
bone tissue engineering.
The group of Gu¨mu¨s-dereliog˘lu studied the applicability
of alginate-based bioinks to print bone tissue from a pre-
osteoblast mouse cell line.66 The alginate bioinks employed
in this study (3.0% wt/vol) were prepared by internal gelation
using Ca2SO4 (1.0% wt/vol) to guarantee the formation of
homogeneous gels. This procedure was followed by external
gelation with CaCl2 (2.0% wt/vol) for 15 min. This method
allowed a uniform distribution of ions throughout the system,
providing the gel with structural homogeneity. Some of the gels
reported in this study incorporated hydroxyapatite particles
(20 mg mL1), which have been proven to increase cell attach-
ment and lead to osteogenic differentiation from osteogenic
progenitor cells.67,68 The hydroxyapatite particles were mixed
homogeneously with the bioink–cell mixture during the manu-
facturing process. This enabled a good cell–particle interaction;
moreover, the presence of hydroxyapatite further increased the
viability and proliferation of the pre-osteoblast cells.
The preparation of 3D printed scaffolds for bone tissue
engineering was also explored by the group of Grandfield,
who created an osteoblast in vitro model, by printing an
alginate bioink with the ExCeL technique (combining Extrusion
printing on Cellulose scaffolds with Lamination).69 This tech-
nique uses chromatography paper impregnated with the cross-
linker (CaCl2) as a support for the 3D printed scaffolds. Firstly,
the paper was prepared by printing a CaCl2 solution (0.1 or 1 M)
onto it followed by drying overnight. Then, the alginate bioinks
(2.0 or 3.0% wt) containing osteoblasts were printed on the
paper and became immediately cross-linked when in contact
with it. Interestingly, the different cross-linker and alginate
concentrations yielded two gels with different Young’s moduli,
which induced different cell behaviour. The stiffer gels were
more compatible with the formation of the osteocyte-like cells
from the osteoblasts, with good overall cell viability.
Kelly and co-workers explored the applicability of alginate
bioinks to support the growth of MSCs and their differentiation
into chondrocytes.70 The bioinks were prepared using a 2.45%
wt/vol concentration of alginate in Dulbecco’s modified Eagle’s
Medium (DMEM) and porcine articular cartilage extracellular
matrix (cECM) in a 0.2 or 0.4% wt/vol concentration. A pre-
crosslinking step, by addition of a 0.018 M solution of CaCl2,
was initially performed to improve the viscosity of the formulation,
which also showed shear-thinning and thixotropic behaviour. The
bioinks were then fully cross-linked after printing in a 0.06M CaCl2
bath for 20 minutes. The encapsulated cells displayed high viability
(470%) in all of the bioinks 24 hours after printing and the
obtained constructs were stable for over 42 days of culture.
All the prepared bioinks induced chondrogenesis, however those
containing the highest cECM concentration (0.4%) were found to
be more chondro-inductive than the others. Since the compressive
stiffness of the bioinks was lower than that of native articular
cartilage, the cECM bioinks were subsequently reinforced with a
supporting polycaprolactone (PCL) framework, resulting in hybrid
constructs with biomimetic mechanical properties.
Fibroblast and vascular scaffolds
A number of alginate bioinks were used to prepare fibroblast
constructs. Park and co-workers, for example, explored the
effect of different concentrations of low and high-molecular
weight alginate bioinks on fibroblast growth.39 The best
results in terms of processability and shapes were obtained
using a 3.0% wt bioink composed of a 1 : 2 ratio of low- and
high-molecular weight alginate (respectively 143 and 350 kDa).
These formulations were successfully used to print and
grow fibroblasts, which displayed good viability in the 3D
printed scaffolds after seven days of culture. Further studies
were performed by the group of Chrisey, who optimised
the conditions to fabricate 3D alginate vascular constructs
by laser printing.71 The inks containing alginate alone
(8.0% wt/vol) or in combination with fibroblasts (2.0% wt/vol
alginate) were laser-printed layer by layer into straight or
Y-shaped tubes and cross-linked using respectively 2.0% or
1.0% wt/vol CaCl2. In both cases, the post-printing cell-
viability immediately after printing and after incubation for
24 hours was above 60%.
The group of Yeong also used alginate-based gels (6.0% wt/vol)
to fabricate vascular-like tubular structures using a multi-
nozzle extrusion-based technique.72 This method was based
on the concurrent deposition of cross-linking agent (CaCl2
500 mM) into concentric tubular walls during each layer of
deposition. Alginate was selected as the model material to
demonstrate the feasibility of this versatile and simple method.
Further studies on the formation of vascular constructs were
undertaken by He and co-workers, who developed novel
3D-printed alginate structures by extrusion.61 The alginate
bioinks (2.0–4.0% wt/vol) were loaded with fibroblasts and
smooth muscle cells and the 3D printed structures were
cross-linked with CaCl2 4.0%. The vascular structures were
obtained by extruding and printing along a rotated rod template.
Endothelial cells were then seeded into the inner wall. The most
successful formulation used in this study, contained a 4.0% wt/vol
alginate concentration. The fibroblasts encapsulated in the
structures showed over 90% survival after 1 week.
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It is interesting to note here that all vascular constructs
discussed above were prepared using higher alginate concen-
trations compared to 3D scaffolds of MSCs. This is probably
because these types of structures are often more complex than
others in terms of shape and number of 3D printed layers and,
therefore, require a higher stability and rigidity, which can be
achieved using higher polymer concentrations.
Neural scaffolds
Alginate-based bioinks were also found to be suitable with
nerve tissue engineering. The group of Dia´z–Dia´z explored this
in detail in a recent review, where they discussed the applica-
tions of alginate hydrogels as scaffolds and delivery systems to
repair the damaged spinal cord.73 When applying alginate
bioinks for nerve tissue engineering, very low-concentration
alginate hydrogels (0.2–1.0% wt/vol) were more favourable
to keep cell viability and function.35,74 However, low alginate
concentration also leads to problems with poor printability and
stability of the 3D printed constructs.75,76 The group of
Chen tried to overcome these problems by printing low concen-
tration alginate bioinks incorporating Schwann cells on pre-formed
sacrificial gelatin scaffolds.77 The bioinks were prepared using 0.5,
1.5 and 3.0% wt alginate concentrations and displayed differences
in their swelling and degradation profiles. The scaffolds were
fabricated by an indirect bioprinting process, which involved
different steps (Fig. 3). Sacrificial gelatin scaffolds (50.0% wt/vol)
were initially prepared (Fig. 3a) and subsequently impregnated
with the alginate solutions (Fig. 3b). These were cross-linked with
CaCl2 (50 mM) added on top of the frameworks. The scaffolds
were then refrigerated for 18 hours and placed in an incubator
with 5.0% CO2 at 37 1C to melt, and hence remove the gelatin
(Fig. 3c). As might be expected, the best results in terms of
stability of the resulting 3D printed constructs were obtained
with the highest alginate concentrations (1.5 and 3.0% wt/vol,
Fig. 3b and c). However, the scaffolds prepared with the lowest
alginate concentration showed the best results in terms of cell
growth, migration and proliferation.
A similar approach, in this case described as ‘FRESH’
(freeform reversible embedding of suspended hydrogels),
was adopted by the group of Hermanson, who reported a
moderately low concentration alginate bioink (2.0% wt/vol)
for 3D bioprinting of human neuroblastoma cells.78 A gelatin
slurry was used for physical support during printing and CaCl2
(100 mM) was used as an ionic cross-linker for the alginate
chains. The gelatin sacrificial template was then removed by
incubating the scaffolds at 37 1C. The cells embedded in the
scaffolds showed good viability and proliferation after 7 days
from printing.
It is important to note here how lower alginate concentra-
tions are more favourable to grow neural tissues. However,
since these often lead to poorly printable and stable 3D printed
scaffolds, the use of sacrificial gelatin templates seems to be an
effective solution. Exploring bioinks with different alginate and
cross-linker concentrations or prepared in combination with
other additives is probably an area that it would be worth
further investigating to identify optimal conditions for neural
tissue growth.
Hepatocyte scaffolds
Alginate-based bioinks were also employed to 3D print hepato-
cyte constructs. The group of Shu, for example, explored the
conditions to bioprint hepatocyte-like cells without affecting
their biological function and pluripotency.79 The printing process
was performed by extrusion using a 1.5% wt/vol concentration of
Fig. 3 Schematic representation of 3D printing using a sacrificial framework. (a) Gelatin sacrificial framework and 3D printed structures before (b) and
after removal of the sacrificial framework (c), using alginate loadings of 1.5% wt/vol (right) and 3.0% wt/vol (left). (a–c) Reprinted from ref. 77 – S. Naghieh,
M. D. Sarker, E. Abelseth and X. Chen, Indirect 3D bioprinting and characterization of alginate scaffolds for potential nerve tissue engineering applications,
J. Mech. Behav. Biomed., 2019, 93, 183–193. Copyright (2019), with permission from Elsevier.
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sodiumalginate,whichwaspreviously combinedwith the cells and
cross-linkedwithCaCl260mM.Thiswas followedby a secondpost-
printing cross-linking step using BaCl2 (55 mM). Interestingly, the
nozzle length affected the post-printing viability of the cells. The
best results were obtained when shorter nozzles were used.
All of these studies demonstrate the versatility of alginate
bioinks, which can display different mechanical properties
depending on the alginate concentration and the cross-linker.
This allows tailoring of the resulting bioink to create a suitable
environment for different cell types. In particular, we note the
approaches to bioprinting which make use of temporal control,
such as sacrificial scaffolds or later additional cross-linking
steps – in this way, the properties of a scaffold can be modu-
lated at different points in a 3D printing and cell growth
experiment, providing a degree of fine control.
Multicomponent bioinks obtained
combining alginate with other
polysaccharides
As discussed above, alginate alone can be applied to obtain 3D
printed constructs of a wide range of cell types. However, the
majority of alginate-based bioinks reported in the literature are
formulated by combining alginate with other polymers. This
allows the rheology and the stability of the resulting bioinks to
be improved, adapting their properties to specific applications.
We herein report the main types of bioink formulations
prepared by combining alginate with other polysaccharides
(i.e. agarose, cellulose, methylcellulose, hyaluronic acid and
gellan gum; Fig. 4). We aim to highlight here how such formula-
tions are prepared and how the properties of the alginate-based
bioinks are improved by the addition of the second polysaccharide
component. We note that the systems including sacrificial gelatin
described in the previous section also make use of a secondary
component to assist with printability, but in this case, the gelatin
was removed from the hybrid material prior to the main phase
of cell growth, and therefore we categorised those systems as
‘alginate-only’.
Bioink formulations based on alginate and agarose
Agarose is a biopolysaccharide derived from agar, a natural
product extracted from red seaweed. It is composed of basic
repeating units of agarobiose, consisting of 1,3-D-galacto-
pyranose and 3,6-anhydro-a-L-galactopyranose (Fig. 4a). This
polymer undergoes thermal cross-linking and forms hydrogels
on cooling at relatively low temperatures (around 40 1C).80 The
sol–gel transition temperature depends on several factors,
including the average molecular weight of agarose and its
concentration in aqueous solution. Agarose hydrogels are bio-
compatible and have been applied in tissue engineering and drug
delivery.81–84 A number of agarose-based bioinks have been
reported in literature, however, despite its excellent gelation
properties, this material is brittle, has a limited ability to support
cell growth and, being very viscous, is not suitable with droplet-
based bioprinting techniques. Another limitation is that, since it
requires a heat–cool cycle to undergo gelation, it needs tempera-
ture control in the reservoir and during the printing process.
These limitations can be addressed by blending it with other
polymers, such as alginate, that can improve cell viability and
printability. Agarose–alginate blends have been mainly reported
as bioinks for the 3D printing of cartilage, neural and endothelial
constructs.
Cartilage scaffolds. Agarose-based bioink formulations for
3D printed cartilaginous scaffolds were described by Kelly and
co-workers, who compared the capability of four different
bioinks based on agarose, alginate, gelatin methacryloyl (GelMA)
and poly(ethylene glycol) methacrylate (PEGMA) to induce the
in vitro development of hyaline cartilage or fibrocartilage.85 This
experiment was conducted by culturing mesenchymal stem cells
in the different bioinks, treated with the growth factor TGF-b3,
and by checking the markers corresponding to each cartilage
type. In this case printing was carried out by extrusion. Interest-
ingly, alginate and agarose bioinks (respectively 3.5 and 2.0%
concentration) better supported the development of hyaline-like
cartilage, whereas the other two inks facilitated the development
of fibrocartilaginous tissue. The alginate gel used in this study
was supported by an agarose framework. The bioink was pre-
pared by dissolving alginate in PBS and combining the resulting
Fig. 4 Chemical structure of (a) agarose, (b) cellulose, (c) methylcellulose, (d) gellan gum and (e) hyaluronic acid.
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solution with the cells and a 60mMCaCl2 solution. This was then
poured into a 4.0 wt% agarose solution mixed with 60 mM CaCl2
and allowed to cross-link for 30 min at 37 1C.
The use of agarose–alginate composites as bioinks for the
3D printing of cartilage constructs was studied by O’Connell’s
group, who compared different alginate–agarose bioink formu-
lations to the poloxamer Pluronic, which is known to have good
printing properties.86 The ink composition with the best rheo-
logical properties for bioprinting (i.e. yield stress and storage
modulus) was a 5.0% wt/vol bioink composed of alginate and
agarose in a 2 : 3 ratio. This gel displayed the best printing
fidelity, maintained excellent cell viability after printing (more
than 95%), and had continuous matrix production throughout
the culture period.
Neural scaffolds. The 3D printing of neural constructs is
another application of agarose–alginate bioinks. The group of
Crook described a three-component formulation comprising
agarose, alginate and carboxymethyl-chitosan, which could
encapsulate human neural stem cells and support the in situ
differentiation to functional neurons and supporting neuroglia.87
In the resulting bioink, alginate and agarose provided the
required viscosity for printing and the structural support to the
3D printed structure after gelation, whereas the carboxymethyl-
chitosan guaranteed cell survival within the construct. This
formulation contained 5.0% wt/vol alginate, 1.5% wt/vol agarose
and 5.0% wt/vol carboxymethyl-chitosan. Interestingly, the
concentration of agarose in the ink had a remarkable influence
on viscosity and the 3D resolution of the printed objects. Inks
with lower (0.5% wt/vol) or higher agarose content (2.5% wt/vol)
than the optimal concentration (1.5% wt/vol), did not display
ideal printing viscosities and the resulting 3D structures were
poorly defined. In subsequent work, the researchers used this
bioink formulation to bioprint induced pluripotent stem cells
(iPSCs).88 The cells were encapsulated into the polymer blend
before printing and could proliferate within the 3D printed
constructs and differentiate into self-organizing embryoids or
neural tissues containing migrating neurons and neuroglia.
Endothelial scaffolds. More recently, Ye and co-workers
reported an alginate–agarose hydrogel composite treated with
platelet-rich plasma (PRP), which was used as a bioink for
the 3D printing of human umbilical vein endothelial cells
(HUVECs).89 This formulation was deposited on the internal
pores of a heart-shaped polyvinyl alcohol (PVA) sacrificial
scaffold, which was then removed by immersion and multiple
washings in cell culture medium (DMEM) to give a flexible,
hollow, micro-fluid channel network structure. The alginate–
agarose blend was prepared in phosphate buffer saline (PBS)
solution using 2.0% wt/vol alginate with different concentra-
tions of low-melting point agarose (0.6%, 1.2%, 1.8% and
2.4% wt/vol). These were combined with PRP and cross-linked
with 2.0% CaCl2. The agarose concentration was crucial to
determine the viscosity of the resulting bioinks, optimal print-
ability and stability of the 3D printed shapes. In this case, the
viscosity of the inks containing the highest agarose concen-
tration gave the best results in terms of processability and
stability of the printed object. By contrast, the inks prepared
with lower agarose concentrations were too liquid to allow
effective ink deposition on the sacrificial PVA template.
Bioink formulations based on alginate and cellulose
Cellulose is a natural polysaccharide composed of b(1–4)-linked
D-glucose units (Fig. 4b). It can be obtained from plants or
bacterial biosynthesis. Cellulosic extracts with one dimension
in the nanometre range are also known as nanocellulosic
materials and can be classified as nanofibrillated cellulose
(NFC) and cellulose nanocrystals (CNCs).90 NFCs are long
cellulose fibrils containing amorphous and crystalline regions,
extracted from plants by a combination of mechanical and
chemical treatments. Such fibres can form highly entangled
networks in aqueous media with high viscosity at very low
concentrations (below 1% wt/vol). CNCs, on the other hand,
are crystalline rod-like particles, mainly extracted by acid
hydrolysis. This process disrupts the amorphous fibre domains,
allowing the isolation of crystal nanoparticles with well-defined
shapes. Being a natural, abundant, environmentally friendly,
cost-effective, biodegradable and biocompatible resource, hydro-
gels from cellulose have been widely employed in tissue engi-
neering, drug delivery and wound healing.91–96 A wide variety of
cellulose bioinks has been reported in the literature, especially in
the last few years.97–101 The combination of this polysaccharide
with alginate yielded a number of different formulations, which
were mainly applied for the 3D printing of cartilage scaffolds.
Cartilage scaffolds. The group of Gatenholm is one of the
leading groups in the field and has studied in detail the
properties and applications of nanocellulose–alginate bioinks.
In 2015, they reported various NFC–alginate blends composed
of different ratios of the two polymers and studied the printing
parameters and shape fidelity.102 The polymer mixtures were
prepared using a 2.5% wt/vol NFC dispersion and 2.5% wt/vol
alginate solution combined in different ratios: 90 : 10, 80 : 20,
70 : 30 and 60 : 40 and cross-linked with a 90 mM CaCl2
solution. All the inks displayed similar viscosity and shear
thinning behaviour. Interestingly, before cross-linking, the
properties of the NFC were dominating, allowing shear thin-
ning behaviour, high printing resolution and shape fidelity.
After cross-linking, the alginate properties dominated, with
higher elastic modulus values for the gels that contained a
higher amount of alginate. These bioinks were used to bioprint
chondrocyte scaffolds, which showed good cell viability after
7 days of culture. In subsequent work, they studied the applic-
ability of a commercially available NFC–alginate bioink
(‘CELLINK’) to bioprint complex cell-laden cartilage constructs
(e.g. a human ear-shaped scaffold) with controlled cell density
and porosity.18 The bioink used in this project contained 2.0%
wt/vol NFC and 0.5% wt/vol alginate and it was cross-linked
after printing in a 100 mM CaCl2 bath. The ear-shaped constructs
showed high shape stability after printing and were used to grow
auricular and nasal chondrocytes with good cell adhesion,
proliferation and maintenance of chondrogenic phenotype.
Interestingly, the seeded cells underwent chondrogenesis in the
bioink, with neo-synthesis and accumulation of cartilage-specific
extracellular matrix around the cells.
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To improve the delivery of bioactive molecules from such
formulations, these researchers subsequently developed a
NFC–alginate bioink using a sulfated form of alginate.103 This
chemical modification allowed the binding of growth factors
and induced collagen II deposition and the proliferation of
encapsulated bovine chondrocytes. These bioinks were prepared
using 1.0% wt/vol alginate sulfate and 1.36% wt/vol nano-
cellulose, and were cross-linked after printing with a 100 mM
CaCl2 solution. The obtained formulation allowed the printing of
complex 3D structures with high shape fidelity. The cell behaviour
was greatly influenced by the printing conditions, with the best
results in terms of preservation of cell function obtained using
wide diameter conical needles.
In more recent work, the team investigated the printability
of mechanically processed lipoaspirate (i.e. fat tissue removed
by liposuction) containing adipose-tissue derived stem cells
(ASCs), in combination with a NFC–alginate blend (Fig. 5).104
The resulting bioink (containing NFC and alginate in a 4 : 1
ratio) was studied in terms of printability and in vivo cell
survival, and neovascularization of the obtained bioprinted
grafts. The collected results demonstrated the applicability
of this bioink to print complex and heterogeneous tissues
containing various cell types including adipocytes, endothelial
cells and ASCs. The 3D constructs preserved both structure and
cellular composition; moreover 30 days after the scaffold was
subcutaneously implanted in the neck of nude mice, evidence
of vascularization was confirmed. This work is of great impact,
as it clearly demonstrates the in vivo applicability and potential
clinical use of such 3D printed constructs.
Further studies on NFC–alginate bioinks were carried out by
Simonsson and co-workers, in collaboration with the group of
Gatenholm. They compared the performance of such formula-
tions to a bioink polymer blend composed of hyaluronic acid
(HA) and NFC.105 The inks were used to bioprint human
pluripotent stem cells. Interestingly, the NFC–alginate ink
had a much better performance than the NFC–HA ink, which
showed little or no proliferation of the encapsulated cells.
This result is quite surprising, considering that hyaluronic acid
is a natural component of cartilage106 and has been proven to
encapsulate human stem cells and support their 3D growth.107
The authors hypothesized that it may have been caused by the
HA cross-linker (hydrogen peroxide – H2O2), which may have
induced phenotypic changes in the cells encapsulated into
the NFC–HA gel. The best results were obtained for the NFC–
alginate bioink containing the two components in a 60 : 40 ratio
(dry weight%), which were cross-linked with 100 mM CaCl2.
The 3D printed scaffolds obtained using this bioink showed
good cell viability, high cell density and the formation of
spherical cell clusters initially and then cartilaginous tissue
after 5 weeks. The NFC–alginate constructs prepared with a
80 : 20 ratio of the two polymers, displayed a higher stability
compared to the 60 : 40 bioink, but a lower cell survival rate.
The live cells in this bioink, however, were evenly distributed
and proliferated into elongated cell clusters. This illustrates
how multicomponent systems can be easily tuned by simple
formulation to achieve different outcomes.
Kolbi and co-workers explored the applicability of NFC–
alginate bioinks to cultivate and grow mesenchymal stem cells
and chondrocytes together.108,109 In their research, they used
the commercially available CELLINK formulation to bioprint
3D constructs, which were implanted into nude mice to induce
the in vivo formation of viable cartilage. This study was performed
by encapsulating in the ink human nasal chondrocytes in combi-
nation with MSCs. The chondrocytes displayed good viability,
proliferation and cartilage-cluster formation and the MSCs
induced enhanced chondrocyte proliferation.
Bioink formulations based on alginate and methylcellulose
Methylcellulose is a methyl ether of cellulose containing 27.5–
31.5% methoxy groups (Fig. 4c). This polymer is widely used as
a thickener and emulsifier in food and cosmetic products.110
It forms thermo-reversible hydrogels and can be applied for a
variety of biological applications such as cell culture, wound
healing and tissue engineering.111,112 Due to its ease of gelation
and biocompatibility, it is an ideal ingredient for bioink
formulations.
The properties and printability of several methylcellulose–
alginate bioink formulations were studied by the group of Chen,
who explored the swelling, degradation rate and mechanical
properties of various polymer blends in comparison to pure
alginate.113 Four different formulations were analysed: pure
alginate (3.0% wt/vol), gelatin–alginate composite (1.0% wt/vol
gelatin and 3.0% wt/vol alginate), methylcellulose–alginate com-
posite (1.5% wt/vol methylcellulose and 1.5% wt/vol alginate)
and gelatin–methylcellulose–alginate composite (1.0% wt/vol
gelatin, 0.5% wt/vol methylcellulose and 1.5% wt/vol alginate).
It was demonstrated that the polymer blends had a higher water
absorption ability compared to pure alginate. Moreover, they
displayed a higher capability to retain compressive strength over
time. Interestingly, the methylcellulose–alginate bioink had the
highest elastic modulus (113.3 kPa) compared to the other
formulations, which had G0 values between 69.4 and 82.85 kPa
depending on the ink composition.
Fig. 5 3D printing of NFC–alginate blend combined with mechanically
processed lipoaspirate. Reprinted from ref. 104–K. Sa¨ljo¨, L. S. Orrhult,
P. Apelgren, K. Markstedt, L. Ko¨lby and P. Gatenholm, Successful engraft-
ment, vascularization, and In vivo survival of 3D-bioprinted human
lipoaspirate-derived adipose tissue, Bioprinting, 2020, 17, e00065.
Copyright (2020), with permission from Elsevier.
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A number of methylcellulose–alginate bioinks have been
reported and applied to make 3D scaffolds of various cell types
including, amongst others, fibroblasts, MSCs and chondrocytes.
Fibroblast scaffolds. Li and co-workers investigated the
properties of highly robust, high loading methylcellulose–
alginate blends for the 3D printing of fibroblasts.114 The bioink
that gave the best results was composed of 3.0% wt/vol alginate
and 9.0% wt/vol methylcellulose and showed thixotropic beha-
viour and great extrudability. This formulation allowed the
fabrication of constructs with 150 overlapping layers. The
encapsulated fibroblasts displayed good cell morphology and
viability after 5 days of culturing. The prepared bioinks were
treated with the chelating agent trisodium citrate to remove
interfacial calcium ions. A subsequent post-cross-linking
process by immersion of the 3D printed constructs into a CaCl2
bath helped to build new more robust interfacial connections
between layers, improving the interfacial bonding strength.
Mesenchymal stem cells, cartilage and bone scaffolds. The
group of Lode reported an a methylcellulose–alginate bioink
with high stability and elasticity, for the encapsulation and 3D
bioprinting of MSCs.115Once again, this ink was produced using a
high total loading of 3.0% wt/vol alginate and 9.0% wt/vol
methylcellulose (1 : 3 ratio), increasing the ink viscosity and
microporosity, and tuning the rheological properties of the final
ink formulation. Post-printing cross-linking was performed using
a 100 mM CaCl2 solution. The MSCs were incorporated into the
ink before 3D bioprinting and showed good viability up to 3 weeks
of cultivation. The cells embedded into the 3D printed constructs
maintained their differentiation potential over time by means of
differentiation into adipocytes when the cells were incubated for
21 days with adipogenic medium.
More recently, this research group, in collaboration with
Gelinsky and co-workers, performed a systematic study on the
influence of different sterilization techniques (i.e. autoclave,
supercritical CO2 treatment, and UV and g irradiation) on the
material properties of such methylcellulose–alginate bioinks
(3.0% wt/vol alginate and 9.0% wt/vol methylcellulose), as well
as the cellular responses.116 These bioinks were used for the
bioprinting of embedded bovine chondrocytes. Cross-linking
with a 100 mM CaCl2 solution was performed after printing.
The experiments demonstrated that exposure to g irradiation
had an impact on the polymer blend viscosity and stability after
extrusion, both of which were lower compared to those of
the bioinks exposed to the other treatments. Moreover, this
sterilization method influenced the methylcellulose chain
mobility within the gel network after alginate cross-linking
with Ca2+ ions. The best results in terms of cell survival and
function were displayed by the gels treated with supercritical
CO2 or UV irradiation.
Methylcellulose–alginate bioinks can also be combined with
other components to direct cell behaviour. Gelinsky and co-workers
have investigated the effect of the incorporation of LAPONITEs,
a synthetic nanosilicate clay, on the printing properties of a
methylcellulose–alginate blend.117 This bioink was prepared by
combining a 3.0% wt/vol alginate solution with LAPONITEs
(3.0% wt/vol) and different methylcellulose concentrations
(3.0%, 6.0% or 9.0% wt/vol). The bioink was cross-linked with
CaCl2 (100 mM). This blend was used to create 3D scaffolds
incorporating MSCs with high printing fidelity and showing
cell viability for more than 21 days. Since LAPONITEs is known
for its drug delivery properties, to prove the applicability of this
hydrogel composite as a drug delivery system, the bioink was
loaded with two model proteins (bovine serum albumin (BSA)
and vascular endothelial growth factor VEGF)). The release of
these proteins from the hydrogel in the cell medium was
significantly improved in the presence of LAPONITEs com-
pared to the same inks without LAPONITEs, although a high
amount was retained. To verify if the released proteins could
keep their function, they incubated endothelial cells in the
release medium from VEGF-laden scaffolds. The cells showed
enhanced proliferation in comparison to the negative controls.
More recently, these researchers explored the effect of
adding calcium phosphate cement (CPC) to a methylcellulose–
alginate bioink (3.0% wt/vol alginate and 9.0% wt/vol methyl-
cellulose) with embedded MSCs.118 The preparation of this
formulation required a certain degree of optimization in terms
of printability and cell survival inside the bioinks. Once optimal
conditions were identified, the system could be applied to
prepare 3D osteochondral tissue grafts models.
Other applications. The group of Gelinsky has published a
remarkable number of scientific articles on 3D bioprinting of
methylcellulose–alginate composites. In one of the reported
studies, using a highly viscous blend (3.0% wt/vol alginate and
9.0% wt/vol methylcellulose), cross-linked with SrCl2, to obtain
3D printed constructs of viable and functional pancreatic islets
from rats.119 The printed cells kept their function and mor-
phology and it was possible to recognize a and b pancreatic
cells within the islets.
Further research described the properties of a more complex
formulation composed of methylcellulose (3.0% wt/vol), alginate
(2.8% wt/vol) and agarose (0.9% wt/vol), which was used for the
incorporation and bioprinting of plant cells.120 The bioink con-
taining a living cell culture of basil was printed by extrusion using
different ratios of the three polymers. They observed that the
methylcellulose concentration was crucial to ensure good print-
ability and maintain shape fidelity. Bioinks containing lower
methylcellulose content, displayed low viscosity, loss in 3D printing
definition and loss of stability of the 3D printed constructs and in
their capability to retain the shape. Cell survival on the printed
structures was confirmed by live/dead staining, microscopy and
metabolic measurements.
Bioink formulations based on alginate and gellan gum
Gellan gum is a biopolymer of bacterial origin, produced by
the bacterium Sphingomonas Elodea. This polysaccharide is
composed of tetrasaccharidic repeating units consisting of
two residues of D-glucose, one residue of L-rhamnose and one
residue of D-glucuronic acid (Fig. 4d). Hydrogels of gellan gum
are obtained by thermal trigger or/and by cross-linking with
divalent cations, such as Ca2+, Ba2+ and Sr2+.80,121,122 Such
hydrogels have been widely applied in the food industry,123,124
however, more recently they have also been shown to be suitable
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for drug delivery and tissue engineering applications.121,122,125
Being biocompatible, gellan gum is an ideal component to improve
the mechanical properties of alginate bioink formulations.
Mesenchymal stem cells, cartilage and bone scaffolds.
Zenobi-Wong and co-workers reported a gellan gum-alginate
bioink with shear-thinning behaviour and optimal printability,
which was cross-linked by delivering cations by co-extrusion of
a cation-loaded transient support polymer (30% pluronic in
NaCl and SrCl2).
126 This ink was prepared by combining
3.0% wt/vol gellan gum with 2.0% wt/vol alginate and it was
used to produce various types of grafts with different 3D shapes
(i.e. human ear, nose, meniscus and vertebral disk). These
grafts were treated with cartilage extracellular matrix particles
(BioCartilage), and it was shown that this bioink could support
proliferation of chondrocytes and the deposition of cartilage
matrix proteins. This was observed to a higher extent when
the bioinks were treated with the chondrogenic protein trans-
forming growth factor b (TGF-b).
In subsequent work, these researchers described the effect
of incorporating cationic-modified silica nanoparticles into an
anionic polymer blend composed of alginate and gellan gum
(3.0% and 3.5% wt/vol, respectively).127 This combination
resulted in a significant increase in zero-shear viscosity
(1062%) and storage modulus (486%). The presence of the
silica nanoparticles therefore allowed an increase of stability
and shape fidelity of the 3D printed constructs, which did not
collapse during printing. Interestingly, the size of the nano-
particles had to be o100 nm to guarantee such mechanical
enhancement and they also reduced shrinking and swelling of
the obtained constructs. In general terms, the impact of nano-
particles on the mechanical performance of soft materials is
quite well-known.128–131 More importantly, the incorporated
nanoparticles did not affect the bioink biocompatibility with
the growth of encapsulated chondrocytes, which displayed high
cell viability (490%) and matrix production.
The use of gellan gum–alginate bioinks for 3D printing and
in situ differentiation of MSCs was investigated by the group of
Gelinsky. Highly stable bioinks with good processability and
enhanced mechanical properties were obtained by combining
3.0% wt/vol gellan gum with 2.0% wt/vol alginate, cross-linked
with 1 M CaCl2.
132 Compared to 3D printed scaffolds of pure
alginate, the presence of gellan gum improved mechanical
strength, shape fidelity and decreased the swelling in cell
culture medium. The prepared bionks were compatible with
the growth of MSCs and supported osteogenic differentiation.
However, after two weeks of culture the number of viable cells
decreased. Long-term cell culture may be improved using other
divalent cations (e.g. Sr2+), which form more stable cross-linked
hydrogels and are therefore more suitable for long term
studies.133,134 Another option could be coating with a peptide
that encourages cell proliferation, such as the tripeptide
Arg-Gly-Asp (RGD), which has been proven to improve cell
adhesion, spreading and proliferation.22,135–137
The researchers subsequently reported a biphasic scaffold
incorporating VEGF, obtained by combining a gellan-gum/
alginate bioink hydrogel composite with an oil-based calcium
phosphate cement (CPC – Fig. 6a).138 The CPC paste hardens in
water forming nanocrystalline hydroxyapatite. The performed
experiments demonstrated that the bioprinted construct was
compatible with the growth of MSCs, which could differentiate
towards osteoblasts. The VEGF released from the scaffold kept
its function and could stimulate endothelial cell proliferation
and angiogenesis in vitro. The 3D printed scaffold was
implanted into a segmental bone defect in the femur diaphysis
of rats (Fig. 6b and c) and significantly helped reduce the defect
size, by helping the formation of new bone tissue.
Bioink formulations based on alginate and hyaluronic acid
Hyaluronic acid (HA) is a linear natural polysaccharide
composed of D-glucuronic acid and N-acetyl-D-glucosamine
units linked by b (1–3) or b (1–4) bonds (Fig. 4e).139 This anionic
glycosaminoglycan has a molecular weight ranging between 5
and 2000 kDa. Being a component of the extracellular matrix in
most of the connective tissues in the body, it has the advantage
of being non-toxic, non-immunogenic and non-inflammatory.139
Hydrogels of hyaluronic acid can be obtained by covalent cross-
linking and they have been applied in cell culture, tissue engi-
neering, drug delivery and wound healing.140–144 A wide variety of
HA bioink formulations has been reported in the literature,145–148
some of which include hyaluronic acid–alginate blends, which
were suitable for the fabrication of neural and cartilaginous
scaffolds.
Neural scaffolds. Chen’s group focussed on HA–alginate
bioinks encapsulating Schwann cells for potential use in peri-
pheral nerve tissue engineering.149 These formulations contained
hyaluronic acid (0.25%wt/vol) and alginate (2.5% wt/vol) and were
crosslinked with CaCl2 (100 mM). After printing the first layer, the
obtained 3D construct was coated with polyethylenimine (PEI)
Fig. 6 Gellan gum/alginate/CPC 3D printed 75 scaffold (a) immediately
after printing, (b) after implantation into rat femur (post-operative X-ray,
and (c) after explantation after 12 weeks. Adapted from ref. 138 – T. Ahlfeld,
F. P. Schuster, Y. Fo¨rster, M. Quade, A. R. Akkineni, C. Rentsch, S. Rammelt,
M. Gelinsky and A. Lode, Adv. Healthcare Mater., 2019, 8, 1801512.
Copyright 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim, with
permission from Wiley.
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to immobilise the first printed layer onto the platform. Each
subsequent layer was then extruded into a CaCl2 bath to cross-link
the alginate. Polyvinyl alcohol (PVA) and PEI were also added
to improve the shape fidelity and the stability of the resulting
scaffolds. The resulting 3D printed constructs displayed high
structural integrity over time, whilst preserving long-term cell
viability. In subsequent work, the researchers studied more in
detail the effect of the addition of PEI during the fabrication
process of HA–alginate bioinks for 3D printing of Schwann cells
and chondrocytes.150 This polycation has a stabilising effect on
the 3D constructs due to the formation of a polyelectrolyte
complex with the alginate chains. Moreover, it binds ionically to
HA forming a complex between its amino groups and the
carboxylic groups of HA. The bioink formulation was prepared
by combining alginate (2.5% wt/vol) with hyaluronic acid (0.25%
wt/vol) in 0.3 M sucrose and HEPES (25 mM). PVA was also added
to the cross-linking solution (100 mM CaCl2) to further increase
the viscosity and prevent the printed constructs to float in the
cross-linking solution. The performed experiments demonstrated
that the treatment with PEI (0.1%, 0.2% or 0.5% wt/vol) improved
the mechanical properties of the bioink formulation and reduced
the scaffold degradation rate and degree of swelling. However, the
survival rate of the cells encapsulated in the bioink tended to
decrease with increasing PEI concentrations. It is well-known that
polyamines are relatively toxic to cells.151 Therefore, optimal
concentrations of the polycation are required to guarantee opti-
mal outcomes and applicability of the bioinks. This study clearly
demonstrates how highly complex formulations can emerge in
this field of research. This is obviously an advantage of this
approach to tissue engineering, but it is vital to carefully
characterise the impact of each component in the system in order
to best optimise the overall gel for the desired application.
More recently, these researchers developed a more complex
bioink formulation composed of hyaluronic acid, RGD-modified
alginate and fibrin for 3D bioprinting of Schwann cell scaffolds.76
This bioink was prepared by binding alginate to RGD peptide in
a 250 : 1 ratio by coupling reaction in the presence of ethyl-
(dimethylaminopropyl) carbodiimide (EDC) and N-hydroxysuccin-
imide (NHS) and subsequently combining it with hyaluronic acid
to obtain a final 2.0% wt/vol concentration of alginate and 1.0%
wt/vol modified-HA. To evaluate the effect of cross-linker concen-
tration on the stability and shape fidelity of the 3D printed
constructs, they used different CaCl2 concentrations (10, 20, 30
and 40 mM). The collected results showed that the cross-linker
concentration and bioprinting speed had a remarkable effect on
the shape, stability and pore size of the printed structures.
Increasing the Ca2+ concentrations resulted in better shape
fidelity, however excessively high concentrations could result in
structural failure. This is due to the formation of a very rigid
structure in a very short time, which reduces the attachment of
subsequently printed hydrogel layers and hence the stability of the
3D printed construct. The obtained hydrogels could support
Schwann cell viability and function and were shown to be
promising for nerve regeneration.
Cartilage scaffolds. The applicability of HA–alginate based
bioinks for the fabrication of articular cartilaginous constructs
was explored by Antich et al.152 They prepared a bioink for-
mulation containing 1.0% wt/vol HA and 2.0% wt/vol alginate,
which was cross-linked with a 100 mM CaCl2 solution. The
polymer blend displayed good printability, gelling ability, opti-
mal stiffness and degradability. To further improve the stability
of the 3D printed constructs and ensure optimal mechanical
properties for the growth of chondrocytes, the bioink was
deposited on a biodegradable polylactic acid (PLA) framework
and subsequently cross-linked. The resulting scaffold showed
biomimetic mechanical properties and promoted chondro-
genesis – it is therefore a promising material for articular
cartilage regeneration.
Design of alginate-based bioink
formulations for specific applications
3D bioprinting allows the fabrication of complex tissue con-
structs, including 3D scaffolds, hollow tubes and organs. This
technology is rapidly evolving towards functional tissues and
implants for tissue regeneration in vivo applications.153–155
The bioink formulations we have discussed in this review have
been applied for the fabrication of different 3D scaffolds
(e.g. cartilage, bone, fibroblasts, endothelial and neural),
indeed some of these applications have been noted earlier in
the review. The majority of the studies we have reported here
have been focused on the bioink properties, printability and
compatibility with specific cell lines. These are crucial elements
to consider to achieve more complex 3D structures for in vivo
applications.153
In this section, we will try to use this information to generate
a set of design rules to help the design of alginate-based
bioinks for specific cellular types (Fig. 7). We described in
detail the composition of different multi-component alginate/
polysaccharide formulations used for the development of
different 3D scaffolds; therefore, all the specifics of the different
alginate/polysaccharide blends (e.g. concentrations of the
different components, type and concentration of cross-linker) will
not be discussed again, but we will instead provide a high-level
overview of the available formulations for specific applications.
The reader is referred to the previous sections to find more
detailed descriptions of the bioink composition.
Different elements should be taken into consideration when
designing a bioink for a specific application (Fig. 7). In general
these should be considered in the following order to develop
the optimal formulation:
1. What type of alginate should be used? What is the optimal
concentration? What type of cross-linker is ideal and at which
concentration?
2. Does the addition of another polysaccharide improve the
mechanical properties, stability and degradation profile of the
bioink formulation?
3. Does the incorporation of other additives (e.g. growth
factors or nanoparticles) improve biocompatibility or aid cell
differentiation?
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It is well known that hydrogel scaffolds should mimic the
mechanical properties of native tissues to provide an optimal
environment to the cells.22,156 Therefore soft tissues, such as
neural tissue, preferentially grow on soft hydrogels.38 We have
described various examples of bioink formulations for neural
scaffolds in which alginate was the only component.35,73–78
Such scaffolds were fabricated using alginate concentrations
between 0.5–3.0% wt/vol, with the best results in terms of cell
growth at low alginate concentrations.75,76 The use of gelatin
sacrificial templates allowed materials with higher mechanical
stability and better shape fidelity.77,78 The combination of
alginate with other polysaccharides is a way of avoiding the
use of sacrificial templates. Examples of multicomponent
bioinks were obtained by combining alginate with agarose
(1.5% wt/vol)87,88 or hyaluronic acid (0.25% wt/vol),76,149,150
which provided the necessary mechanical support to the 3D
printed structures (Fig. 7).
Fibroblasts, vascular and endothelial constructs can be
fabricated using alginate bioinks prepared with 2.0–6.0% wt/vol
alginate concentrations.61,71,72,157 Again, combination with other
polysaccharides such as agarose (0.6–2.4% wt/vol)89 or methyl-
cellulose (9.0% wt/vol)114 is an option to obtain bioinks with
good extrudability, thixotropic behaviour and enhanced stability
(Fig. 7).
Alginate bioinks can also be used for the 3D printing
of mesenchymal stem cells that can then differentiate into
different lines forming (for example) cartilage70 or bone
scaffolds.65,66,69 In most of the reported examples, these hard
tissue scaffolds were obtained using an alginate concentration
between 2.0–3.0% wt/vol in combination with other additives
such as graphene oxide, hydroxyapatite or growth factors. The
preparation of polysaccharide blends using agarose, cellulose,
methylcellulose, gellan gum and hyaluronic acid can also be a
successful strategy to improve the mechanical properties of
the resulting 3D printed structures and their stability and
integrity over time (Fig. 7). Bioinks based on alginate blends
with cellulose (2.0% wt/vol)102,105,108,109 and methylcellulose
(9.0% wt/vol)115–118 are the most studied and gave promising
results without the need for functional additives. Other poly-
saccharides such as agarose,81,85 gellan gum126,127,132,138 and
hyaluronic acid152 can also be combined with alginate, but the
use of sacrificial templates or other components (e.g. growth
factors, silica nanoparticles or calcium phosphate cement) may
be required to improve the bioink performance.
Finally, 3D printing of other types of tissues (e.g. hepatic or
pancreatic) has also been achieved using alginate (Fig. 7).79,119
However, relatively few research studies have been performed
in this area and, therefore, this may be of interest for further
investigation.
When designing a bioink formulation, it is important to
keep in mind that functional additives can be added to improve
biocompatibility, performance and suitability of the bioink
for a specific application. We have highlighted various exam-
ples throughout the text, which included the use of growth
factors (e.g. TGF-b or VEGF), graphene oxide, hydroxyapatite,
LAPONITEs, silica nanoparticles, etc.66,70,117,118,138 The encap-
sulation of functional additives into alginate bioinks could
also, therefore, be considered. This topic falls outside the
scope of this review, however relevant readings can be found
elsewhere.19,158–164
Conclusions
3D bioprinting of cellular constructs is a rapidly expanding
research area. Alginate is a natural, biocompatible polymer that
has been widely applied in 3D bioprinting. Most of the reported
bioink formulations based on pure alginate were employed to
3D print stem cells, fibroblasts, neurons and hepatocytes.
Alginate has good biocompatibility, and the performance can
be tailored by tuning the molecular weight of the polymer as
well as its loading, the concentration of the divalent metal
crosslinking agent, and the type of crosslinking agent used.
In particular, sources of calcium ions with low solubility have
been used to slowly crosslink alginate systems and generate
more homogeneous materials.
Fig. 7 Design of alginate/polysaccharide bioinks and main applications of the different formulations.
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The properties of alginate-based bioink formulations can
also be tailored by combination with other polysaccharides,
such as agarose, cellulose, methylcellulose, gellan gum and
hyaluronic acid. The preparation of polymer blends allows,
in particular, the mechanical properties and stability of the
resulting 3D printed constructs to be improved, expanding the
range of applications of alginate bioinks in tissue engineering
and regenerative medicine. For different biological applications, it
is vital to tailor the materials properties of the printed object for
the best outcomes, and a multi-component approach using
alginate gels is a powerful way of achieving this. In some cases,
alginate can be combined with sacrificial materials, which can
temporarily reinforce the 3D printed object, while subsequently
being removed either through processes such as melting or
biodegradation. This can provide a degree of temporal control over
the 3D printed materials. We suggest that such control will become
increasingly important in next generation tissue engineering, where
longer-term fates of cellular tissue will need to be directed.
In addition to blending with different polysaccharides, in a
number of cases, other functional additives are also incorporated
into 3D-printed alginate systems. For example, nanoparticles and
clays can have significant impacts on mechanical performance,
biocompatible peptides, such as RGD can improve cellular
proliferation, and by incorporating growth factors, more subtle
effects on cellular proliferation and differentiation can be
exerted. We suggest that the ease of formulating multiple
components into these gels offers them considerable potential
for further development.
In summary, alginate-based bioinks are promising materials,
and we hope that this review will facilitate the identification of
different alginate–polysaccharide bioink formulations, their optimal
applications and will thus help to inform the design of second
generation bioinks, allowing this relatively simple gel system to
achieve more sophisticated control over biological processes.
Conflicts of interest
The authors declare no conflicts of interest.
Acknowledgements
We thank EPSRC for funding (EP/P03361X/1).
References
1 M. Mobaraki, M. Ghaffari, A. Yazdanpanah, Y. Luo and
D. K. Mills, Bioprinting, 2020, 18, e00080.
2 E. Saygili, A. A. Dogan-Gurbuz, O. Yesil-Celiktas and
M. S. Draz, Bioprinting, 2020, 18, e00071.
3 J. A. Semba, A. A. Mieloch and J. D. Rybka, Bioprinting,
2020, 18, e00070.
4 T. Bedir, S. Ulag, C. B. Ustundag and O. Gunduz,Mater. Sci.
Eng., C, 2020, 110, 110741.
5 J. M. Unagolla and A. C. Jayasuriya, Appl. Mater. Today,
2020, 18, 100479.
6 I. Matai, G. Kaur, A. Seyedsalehi, A. McClinton and C. T.
Laurencin, Biomaterials, 2020, 226, 119536.
7 Y. Huang, X.-F. Zhang, G. Gao, T. Yonezawa and X. Cui,
Biotechnol. J., 2017, 12, 1600734.
8 E. Axpe and M. L. Oyen, Int. J. Mol. Sci., 2016, 17, 1976.
9 P. Rastogi and B. Kandasubramanian, Biofabrication, 2019,
11, 042001.
10 A. C. Herna´ndez-Gonza´lez, L. Te´llez-Jurado and L. M.
Rodrı´guez-Lorenzo, Carbohydr. Polym., 2020, 229, 115514.
11 J. Jang, J. Y. Park, G. Gao and D. W. Cho, Biomaterials,
2018, 156, 88–106.
12 S. Das and B. Basu, J. Ind. Inst. Sci., 2019, 99, 405–428.
13 P. S. Gungor-Ozkerim, I. Inci, Y. S. Zhang, A. Khademhosseini
and M. R. Dokmeci, Biomater. Sci., 2018, 6, 915–946.
14 X. Du, J. Zhou, J. Shi and B. Xu, Chem. Rev., 2015, 115,
13165–13307.
15 W. Aljohani, M. W. Ullah, X. Zhang and G. Yang, Int. J. Biol.
Macromol., 2018, 107, 261–275.
16 S. J. Bidarra, C. C. Barrias and P. L. Granja, Acta Biomater.,
2014, 10, 1646–1662.
17 G. Kaklamani, D. Cheneler, L. M. Grover, M. J. Adams and
J. Bowen, J. Mech. Behav. Biomed., 2014, 36, 135–142.
18 H. Martı´nez A´vila, S. Schwarz, N. Rotter and P. Gatenholm,
Bioprinting, 2016, 1–2, 22–35.
19 J. Jia, D. J. Richards, S. Pollard, Y. Tan, J. Rodriguez,
R. P. Visconti, T. C. Trusk, M. J. Yost, H. Yao, R. R.
Markwald and Y. Mei, Acta Biomater., 2014, 10, 4323–4331.
20 H. Onoe, T. Okitsu, A. Itou, M. Kato-Negishi, R. Gojo,
D. Kiriya, K. Sato, S. Miura, S. Iwanaga, K. Kuribayashi-
Shigetomi, Y. T. Matsunaga, Y. Shimoyama and S. Takeuchi,
Nat. Mater., 2013, 12, 584–590.
21 K. Akeda, A. Nishimura, H. Satonaka, K. Shintani, K. Kusuzaki,
A. Matsumine, Y. Kasai, K. Masuda and A. Uchida, Oncol. Rep.,
2009, 22, 997–1003.
22 T. Andersen, P. Auk-Emblem and M. Dornish, Microarrays,
2015, 4, 133–161.
23 X. B. Huang, X. Y. Zhang, X. G. Wang, C. Wang and
B. Tang, J. Biosci. Bioeng., 2012, 114, 1–8.
24 C. Tai, S. Bouissil, E. Gantumur, M. S. Carranza, A. Yoshii,
S. Sakai, G. Pierre, P. Michaud and C. Delattre, Appl. Sci.,
2019, 9, 2596.
25 R. Suntornnond, J. An and C. K. Chua, Macromol. Mater.
Eng., 2017, 302, 1600266.
26 E. Davoodi, E. Sarikhani, H. Montazerian, S. Ahadian,
M. Costantini, W. Swieszkowski, S. M. Willerth,
K. Walus, M. Mofidfar, E. Toyserkani, A. Khademhosseini
and N. Ashammakhi, Adv. Mater. Technol., 2020, 1901044.
27 J. Y. Ma, Y. C. Wang and J. Liu, RSC Adv., 2018, 8,
21712–21727.
28 J. P. Li, M. J. Chen, X. Q. Fan and H. F. Zhou, J. Transl.
Med., 2016, 14, 271.
29 T. Jiang, J. G. Munguia-Lopez, S. Flores-Torres, J. Kort-Mascort
and J. M. Kinsella, Appl. Phys. Rev., 2019, 6, 011310.
30 E. S. Bishop, S. Mostafa, M. Pakvasa, H. H. Luu, M. J. Lee,
J. M. Wolf, G. A. Ameer, T. C. He and R. R. Reid, Genes
Diseases, 2017, 4, 185–195.
Journal of Materials Chemistry B Review
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
0 
A
ug
us
t 2
02
0.
 D
ow
nl
oa
de
d 
on
 8
/1
8/
20
20
 1
0:
24
:0
1 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
J. Mater. Chem. B This journal is©The Royal Society of Chemistry 2020
31 S. J. Song, J. Choi, Y. D. Park, S. Hong, J. J. Lee, C. B. Ahn,
H. Choi and K. Sun, Artif. Organs, 2011, 35, 1132–1136.
32 L. Raddatz, A. Lavrentieva, I. Pepelanova, J. Bahnemann,
D. Geier, T. Becker, T. Scheper and S. Beutel, J. Funct.
Biomater., 2018, 9, 4.
33 R. T. Xiong, Z. Y. Zhang and Y. Huang, J. Manuf. Process.,
2015, 20, 450–455.
34 J. Y. Yan, Y. Huang and D. B. Chrisey, Biofabrication, 2013,
5, 015002.
35 M. Matyash, F. Despang, C. Ikonomidou and M. Gelinsky,
Tissue Eng., Part C, 2013, 20, 401–411.
36 A. D. Augst, H. J. Kong and D. J. Mooney,Macromol. Biosci.,
2006, 6, 623–633.
37 H. J. Kong, M. K. Smith and D. J. Mooney, Biomaterials,
2003, 24, 4023–4029.
38 A. Banerjee, M. Arha, S. Choudhary, R. S. Ashton,
S. R. Bhatia, D. V. Schaffer and R. S. Kane, Biomaterials,
2009, 30, 4695–4699.
39 J. Park, S. J. Lee, S. Chung, J. H. Lee, W. D. Kim, J. Y. Lee
and S. A. Park, Mater. Sci. Eng., C, 2017, 71, 678–684.
40 K. Y. Lee and D. J. Mooney, Prog. Polym. Sci., 2012, 37,
106–126.
41 W. X. Jiao, W. X. Chen, Y. Q. Mei, Y. H. Yun, B. Q. Wang,
Q. P. Zhong, H. M. Chen and W. J. Chen, Molecules, 2019,
24, 4374.
42 F. E. Freeman and D. J. Kelly, Sci. Rep., 2017, 7, 17042.
43 L. D. Loozen, F. Wegman, F. C. O¨ner, W. J. A. Dhert and
J. Alblas, J. Mater. Chem. B, 2013, 1, 6619–6626.
44 J. Zhang, E. Wehrle, J. R. Vetsch, G. R. Paul, M. Rubert and
R. Mu¨ller, Biomed. Mater., 2019, 14, 065009.
45 H. Xu, Z. Zhang and C. Xu, J. Appl. Phys., 2019, 125, 114901.
46 C. K. Kuo and P. X. Ma, Biomaterials, 2001, 22, 511–521.
47 S. Naghieh, M. R. Karamooz-Ravari, M. D. Sarker, E. Karki
and X. Chen, J. Mech. Behav. Biomed., 2018, 80, 111–118.
48 A. G. Tabriz, M. A. Hermida, N. R. Leslie and W. Shu,
Biofabrication, 2015, 7, 045012.
49 T. Y. Wong, L. A. Preston and N. L. Schiller, Ann. Rev.
Microbiol., 2000, 54, 289–340.
50 T. Boontheekul, H. J. Kong and D. J. Mooney, Biomaterials,
2005, 26, 2455–2465.
51 L. Y. Chen, R. Z. Shen, S. Komasa, Y. X. Xue, B. Y. Jin,
Y. P. Hou, J. Okazaki and J. Gao, Int. J. Mol. Sci., 2017,
18, 989.
52 H. J. Kong, D. Kaigler, K. Kim and D. J. Mooney, Biomacro-
molecules, 2004, 5, 1720–1727.
53 T. V. Shkand, M. O. Chizh, I. V. Sleta, B. P. Sandomirsky,
A. L. Tatarets and L. D. Patsenker, Methods Appl. Fluores.,
2016, 4, 4.
54 J. S. Yang, Y. J. Xie and W. He, Carbohydr. Polym., 2011, 84,
33–39.
55 S. Reakasame and A. R. Boccaccini, Biomacromolecules,
2018, 19, 3–21.
56 M. Y. Teo, S. Kee, N. RaviChandran, L. Stuart, K. C. Aw and
J. Stringer, ACS Appl. Mater. Interfaces, 2020, 12, 1832–1839.
57 J. Dohnal and F. Stepanek, Powder Technol., 2010, 200,
254–259.
58 J. H. Y. Chung, S. Naficy, G. G. Wallace and S. O’Leary, Adv.
Polym. Technol., 2016, 35, 439–446.
59 J. T. Delaney, A. R. Liberski, J. Perelaer and U. S. Schubert,
Soft Matter, 2010, 6, 866–869.
60 Y. S. Zhang, Q. M. Pi and A. M. van Genderen, JoVE J. Vis.
Exp., 2017, 126, e55957.
61 Q. Gao, Z. Liu, Z. Lin, J. Qiu, Y. Liu, A. Liu, Y. Wang,
M. Xiang, B. Chen, J. Fu and Y. He, ACS Biomater. Sci. Eng.,
2017, 3, 399–408.
62 T. R. Cuadros, O. Skurtys and J. M. Aguilera, Carbohydr.
Polym., 2012, 89, 1198–1206.
63 S. Ghorbanian, M. A. Qasaimeh, M. Akbari, A. Tamayol and
D. Juncker, Biomed. Microdevices, 2014, 16, 387–395.
64 H. M. Zhao, Y. S. Chen, L. Shao, M. J. Xie, J. Nie, J. J. Qiu,
P. Zhao, H. Ramezani, J. Z. Fu, H. W. Ouyang and Y. He,
Small, 2018, 14, 1802630.
65 G. Choe, S. Oh, J. M. Seok, S. A. Park and J. Y. Lee,
Nanoscale, 2019, 11, 23275–23285.
66 T. T. Demirtas- , G. Irmak and M. Gu¨mu¨s-dereliogˇlu, Biofab-
rication, 2017, 9, 035003.
67 S. Mondal and U. Pal, J. Drug Delivery Sci. Technol., 2019,
53, 101131.
68 G. Wei, C. Gong, K. Hu, Y. Wang and Y. Zhang, Nano-
materials, 2019, 9, 1435.
69 B. E. J. Lee, A. Shahin-Shamsabadi, M. K. Wong, S. Raha,
P. R. Selvaganapathy and K. Grandfield, Adv. Biosyst., 2019,
3, 1900126.
70 S. Rathan, L. Dejob, R. Schipani, B. Haffner, M. E. Mo¨bius
and D. J. Kelly, Adv. Healthcare Mater., 2019, 8, 1801501.
71 R. Xiong, Z. Zhang, W. Chai, Y. Huang and D. B. Chrisey,
Biofabrication, 2015, 7, 045011.
72 E. Y. S. Tan and W. Y. Yeong, Int. J. Bioprint., 2015, 1,
49–56.
73 S. Grijalvo, M. Nieto-Dı´az, R. M. Maza, R. Eritja and
D. D. Dı´az, Biotechnol. J., 2019, 14, 1900275.
74 M. Matyash, F. Despang, R. Mandal, D. Fiore, M. Gelinsky
and C. Ikonomidou, Tissue Eng., Part A, 2011, 18, 55–66.
75 L. Ning, Y. Xu, X. Chen and D. J. Schreyer, J. Biomater. Sci.,
Polym. Ed., 2016, 27, 898–915.
76 L. Ning, N. Zhu, F. Mohabatpour, M. D. Sarker,
D. J. Schreyer and X. Chen, J. Mater. Chem. B, 2019, 7,
4538–4551.
77 S. Naghieh, M. D. Sarker, E. Abelseth and X. Chen, J. Mech.
Behav. Biomed., 2019, 93, 183–193.
78 J. Lewicki, J. Bergman, C. Kerins and O. Hermanson,
Bioprinting, 2019, 16, e00053.
79 A. Faulkner-Jones, C. Fyfe, D. J. Cornelissen, J. Gardner,
J. King, A. Courtney and W. Shu, Biofabrication, 2015,
7, 044102.
80 S. Graham, P. F. Marina and A. Blencowe, Carbohydr.
Polym., 2019, 207, 143–159.
81 G. R. Lo´pez-Marcial, A. Y. Zeng, C. Osuna, J. Dennis,
J. M. Garcı´a and G. D. O’Connell, ACS Biomater. Sci. Eng.,
2018, 4, 3610–3616.
82 E. Mirdamadi, N. Muselimyan, P. Koti, H. Asfour and
N. Sarvazyan, 3D Print. Addit. Manuf., 2019, 6, 158–164.
Review Journal of Materials Chemistry B
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
0 
A
ug
us
t 2
02
0.
 D
ow
nl
oa
de
d 
on
 8
/1
8/
20
20
 1
0:
24
:0
1 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
This journal is©The Royal Society of Chemistry 2020 J. Mater. Chem. B
83 P. Zarrintaj, S. Manouchehri, Z. Ahmadi, M. R. Saeb,
A. M. Urbanska, D. L. Kaplan and M. Mozafari, Carbohydr.
Polym., 2018, 187, 66–84.
84 H. F. Darge, A. T. Andrgie, H. C. Tsai and J. Y. Lai, Int.
J. Biol. Macromol., 2019, 133, 545–563.
85 A. C. Daly, S. E. Critchley, E. M. Rencsok and D. J. Kelly,
Biofabrication, 2016, 8, 045002.
86 G. R. Lo´pez-Marcial, A. Y. Zeng, C. Osuna, J. Dennis,
J. M. Garcı´a and G. D. O’Connell, ACS Biomater. Sci. Eng.,
2018, 4, 3610–3616.
87 Q. Gu, E. Tomaskovic-Crook, R. Lozano, Y. Chen, R. M.
Kapsa, Q. Zhou, G. G. Wallace and J. M. Crook, Adv.
Healthcare Mater., 2016, 5, 1429–1438.
88 Q. Gu, E. Tomaskovic-Crook, G. G. Wallace and J. M. Crook,
Adv. Healthcare Mater., 2017, 6, 1700175.
89 Q. Zou, B. E. Grottkau, Z. He, L. Shu, L. Yang, M. Ma and
C. Ye, Mater. Sci. Eng., C, 2020, 108, 110205.
90 D. Klemm, F. Kramer, S. Moritz, T. Lindstro¨m, M. Ankerfors,
D. Gray and A. Dorris, Angew. Chem. Int. Ed., 2011, 50,
5438–5466.
91 H. Luo, R. Cha, J. Li, W. Hao, Y. Zhang and F. Zhou,
Carbohydr. Polym., 2019, 224, 115144.
92 S. Naz, J. S. Ali and M. Zia, Bio-Des. Manufact., 2019, 2,
187–212.
93 L. H. Nguyen, S. Naficy, R. Chandrawati and F. Dehghani,
Adv. Mater. Interfaces, 2019, 6, 1900424.
94 P. Phanthong, P. Reubroycharoen, X. Hao, G. Xu,
A. Abudula and G. Guan, Carbon Resour. Convers., 2018,
1, 32–43.
95 S. Salimi, R. Sotudeh-Gharebagh, R. Zarghami, S. Y. Chan
and K. H. Yuen, ACS Sustainable Chem. Eng., 2019, 7,
15800–15827.
96 H. Voisin, L. Bergstro¨m, P. Liu and A. P. Mathew, Nano-
materials, 2017, 7, 57.
97 L. Huang, X. Du, S. Fan, G. Yang, H. Shao, D. Li, C. Cao,
Y. Zhu, M. Zhu and Y. Zhang, Carbohydr. Polym., 2019, 221,
146–156.
98 W. Xu, B. Z. Molino, F. Cheng, P. J. Molino, Z. Yue, D. Su,
X. Wang, S. Willfo¨r, C. Xu and G. G. Wallace, ACS Appl.
Mater. Interfaces, 2019, 11, 8838–8848.
99 M. Ojansivu, A. Rashad, A. Ahlinder, J. Massera, A. Mishra,
K. Syverud, A. Finne-Wistrand, S. Miettinen and
K. Mustafa, Biofabrication, 2019, 11, 035010.
100 S. Sultan, G. Siqueira, T. Zimmermann and A. P. Mathew,
Curr. Opin. Biomed. Eng., 2017, 2, 29–34.
101 C. C. Piras, S. Ferna´ndez-Prieto and W. M. De Borggraeve,
Biomater. Sci., 2017, 5, 1988–1992.
102 K. Markstedt, A. Mantas, I. Tournier, H. Martı´nez A´vila,
D. Ha¨gg and P. Gatenholm, Biomacromolecules, 2015, 16,
1489–1496.
103 M. Mu¨ller, E. O¨ztu¨rk, Ø. Arlov, P. Gatenholm and
M. Zenobi-Wong, Ann. Biomed. Eng., 2017, 45, 210–223.
104 K. Sa¨ljo¨, L. S. Orrhult, P. Apelgren, K. Markstedt, L. Ko¨lby
and P. Gatenholm, Bioprinting, 2020, 17, e00065.
105 D. Nguyen, D. A. Ha¨gg, A. Forsman, J. Ekholm,
P. Nimkingratana, C. Brantsing, T. Kalogeropoulos, S. Zaunz,
S. Concaro, M. Brittberg, A. Lindahl, P. Gatenholm, A. Enejder
and S. Simonsson, Sci. Rep., 2017, 7, 658.
106 R. C. Gupta, R. Lall, A. Srivastava and A. Sinha, Front. Vet.
Sci., 2019, 6, 192.
107 N. S. Hwang, S. Varghese, Z. Zhang and J. Elisseeff, Tissue
Eng., 2006, 12, 2695–2706.
108 P. Apelgren, M. Amoroso, A. Lindahl, C. Brantsing,
N. Rotter, P. Gatenholm and L. Ko¨lby, PLoS One, 2017,
12, e0189428.
109 T. Mo¨ller, M. Amoroso, D. Ha¨gg, C. Brantsing, N. Rotter,
P. Apelgren, A. Lindahl, L. Ko¨lby and P. Gatenholm, Plast.
Reconstruct. Surg., 2017, 5, e1227.
110 S. Morozova, Polym. Int., 2020, 69, 125–130.
111 P. L. Nasatto, F. Pignon, J. L. M. Silveira, M. E. R. Duarte,
M. D. Noseda and M. Rinaudo, Polymers, 2015, 7, 777–803.
112 A. Forghani and R. Devireddy, Methods Mol. Biol., 2018,
1773, 41–51.
113 S. Naghieh, M. D. Sarker, N. K. Sharma, Z. Barhoumi and
X. Chen, Appl. Sci., 2020, 10, 292.
114 H. Li, Y. J. Tan, K. F. Leong and L. Li, ACS Appl. Mater.
Interfaces, 2017, 9, 20086–20097.
115 K. Schu¨tz, A.-M. Placht, B. Paul, S. Bru¨ggemeier,
M. Gelinsky and A. Lode, J. Tissue Eng. Regener. Med.,
2017, 11, 1574–1587.
116 E. Hodder, S. Duin, D. Kilian, T. Ahlfeld, J. Seidel,
C. Nachtigall, P. Bush, D. Covill, M. Gelinsky and
A. Lode, J. Mater. Sci.: Mater. Med., 2019, 30, 10.
117 T. Ahlfeld, G. Cidonio, D. Kilian, S. Duin, A. R. Akkineni,
J. I. Dawson, S. Yang, A. Lode, R. O. C. Oreffo and
M. Gelinsky, Biofabrication, 2017, 9, 034103.
118 T. Ahlfeld, F. Doberenz, D. Kilian, C. Vater, P. Korn,
G. Lauer, A. Lode and M. Gelinsky, Biofabrication, 2018,
10, 045002.
119 S. Duin, K. Schu¨tz, T. Ahlfeld, S. Lehmann, A. Lode, B. Ludwig
and M. Gelinsky, Adv. Healthcare Mater., 2019, 8, 1801631.
120 A. Lode, F. Krujatz, S. Bru¨ggemeier, M. Quade, K. Schu¨tz,
S. Knaack, J. Weber, T. Bley and M. Gelinsky, Eng. Life Sci.,
2015, 15, 177–183.
121 M. Das and T. K. Giri, J. Drug Delivery Sci. Technol., 2020,
56, 101586.
122 K. M. Zia, S. Tabasum, M. F. Khan, N. Akram, N. Akhter,
A. Noreen and M. Zuber, Int. J. Biol. Macromol., 2018, 109,
1068–1087.
123 A. M. Fialho, L. M. Moreira, A. T. Granja, A. O. Popescu,
K. Hoffmann and I. Sa´-Correia, Appl. Microbiol. Biotechnol.,
2008, 79, 889.
124 R. M. Banik, B. Kanari and S. N. Upadhyay, World
J. Microbiol. Biotechnol., 2000, 16, 407–414.
125 F. S. Palumbo, S. Federico, G. Pitarresi, C. Fiorica and
G. Giammona, Carbohydr. Polym., 2020, 229, 115430.
126 M. Kesti, C. Eberhardt, G. Pagliccia, D. Kenkel, D. Grande,
A. Boss and M. Zenobi-Wong, Adv. Funct. Mater., 2015, 25,
7406–7417.
127 M. Lee, K. Bae, P. Guillon, J. Chang, O. Arlov and
M. Zenobi-Wong, ACS Appl. Mater. Interfaces, 2018, 10,
37820–37828.
Journal of Materials Chemistry B Review
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
0 
A
ug
us
t 2
02
0.
 D
ow
nl
oa
de
d 
on
 8
/1
8/
20
20
 1
0:
24
:0
1 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
J. Mater. Chem. B This journal is©The Royal Society of Chemistry 2020
128 Z. Azimi Dijvejin, A. Ghaffarkhah, S. Sadeghnejad and
M. Vafaie Sefti, Polym. J., 2019, 51, 693–707.
129 C. Dannert, B. T. Stokke and R. S. Dias, Polymers, 2019, 11, 275.
130 P. Thoniyot, M. J. Tan, A. A. Karim, D. J. Young and X. J.
Loh, Adv. Sci., 2015, 2, 1400010.
131 A. Boonmahitthisud, L. Nakajima, K. D. Nguyen and
T. Kobayashi, J. Appl. Polym. Sci., 2017, 134, 44557.
132 A. R. Akkineni, T. Ahlfeld, A. Funk, A. Waske, A. Lode and
M. Gelinsky, Polymers, 2016, 8, 170.
133 H. Widerøe and S. Danielsen, Naturwissenschaften, 2001,
88, 224–228.
134 Y´. A. Mørch, I. Donati and B. L. Strand, Biomacromolecules,
2006, 7, 1471–1480.
135 F. Yang, C. G. Williams, D.-A. Wang, H. Lee, P. N. Manson
and J. Elisseeff, Biomaterials, 2005, 26, 5991–5998.
136 E. Mauri, A. Sacchetti, N. Vicario, L. Peruzzotti-Jametti,
F. Rossi and S. Pluchino, Biomater. Sci., 2018, 6, 501–510.
137 J. Dumbleton, P. Agarwal, H. Huang, N. Hogrebe, R. Han,
K. J. Gooch and X. He, Cell. Mol. Bioeng., 2016, 9, 277–288.
138 T. Ahlfeld, F. P. Schuster, Y. Fo¨rster, M. Quade, A. R.
Akkineni, C. Rentsch, S. Rammelt, M. Gelinsky and
A. Lode, Adv. Healthcare Mater., 2019, 8, 1801512.
139 X. Xu, A. K. Jha, D. A. Harrington, M. C. Farach-Carson and
X. Jia, Soft Matter, 2012, 8, 3280–3294.
140 E. Ahmadian, A. Eftekhari, S. M. Dizaj, S. Sharifi,
M. Mokhtarpour, A. N. Nasibova, R. Khalilov and M. Samiei,
Int. J. Biol. Macromol., 2019, 140, 245–254.
141 E. Ahmadian, S. M. Dizaj, A. Eftekhari, E. Dalir, P. Vahedi,
A. Hasanzadeh and M. Samiei, Drug Res., 2020, 70, 6–11.
142 E. Hachet, H. Van Den Berghe, E. Bayma, M. R. Block and
R. Auze´ly-Velty, Biomacromolecules, 2012, 13, 1818–1827.
143 C. B. Highley, G. D. Prestwich and J. A. Burdick, Curr. Opin.
Biotechnol, 2016, 40, 35–40.
144 H. Li, Z. Qi, S. Zheng, Y. Chang,W. Kong, C. Fu, Z. Yu, X. Yang
and S. Pan, Adv. Mater. Sci. Eng., 2019, 2019, 3027303.
145 C. C. Clark, J. Aleman, L. Mutkus and A. Skardal, Bioprinting,
2019, 16, e00058.
146 E. A. Kiyotake, A. W. Douglas, E. E. Thomas, S. L. Nimmo
and M. S. Detamore, Acta Biomater., 2019, 95, 176–187.
147 T. Lam, T. Dehne, J. P. Kru¨ger, S. Hondke, M. Endres,
A. Thomas, R. Lauster, M. Sittinger and L. Kloke, J. Biomed.
Mater. Res. B, 2019, 107, 2649–2657.
148 Y. Qiao, S. Xu, T. Zhu, N. Tang, X. Bai and C. Zheng,
Polymer, 2020, 186, 121994.
149 A. Rajaram, D. Schreyer and D. Chen, 3D Print. Addit.
Manuf., 2014, 1, 194–203.
150 A. Rajaram, D. J. Schreyer and D. X. B. Chen, J. Biomater.
Sci., Polym. Ed., 2015, 26, 433–445.
151 A. E. Pegg, Chem. Res. Toxicol., 2013, 26, 1782–1800.
152 C. Antich, J. de Vicente, G. Jime´nez, C. Chocarro, E. Carrillo,
E. Montan˜ez, P. Ga´lvez-Martı´n and J. A. Marchal, Acta
Biomater., 2020, 106, 114–123.
153 S. V. Murphy and A. Atala, Nat. Biotechnol., 2014, 32,
773–785.
154 F. Pati, J. Gantelius and H. A. Svahn, Angew. Chem. Int. Ed.,
2016, 55, 4650–4665.
155 S. Vijayavenkataraman, W. C. Yan, W. F. Lu, C. H. Wang
and J. Y. H. Fuh, Adv. Drug Delivery Rev., 2018, 132,
296–332.
156 A. Seidi, M. Ramalingam, I. Elloumi-Hannachi, S. Ostrovidov
and A. Khademhosseini, Acta Biomater., 2011, 7, 1441–1451.
157 J. Park, S. J. Lee, S. Chung, J. H. Lee, W. D. Kim, J. Y. Lee
and S. A. Park, Mater. Sci. Eng., C, 2017, 71, 678–684.
158 M. Hassan, K. Dave, R. Chandrawati, F. Dehghani and
V. G. Gomes, Eur. Polym. J., 2019, 121, 1–15.
159 J. K. Carrow and A. K. Gaharwar, Macromol. Chem. Phys.,
2015, 216, 248–264.
160 A. Bharadwaz and A. C. Jayasuriya,Mater. Sci. Eng., C, 2020,
110, 110698.
161 A. Bibi, S. U. Rehman and A. Yaseen,Mater. Res. Exp., 2019,
6, 092001.
162 J. Venkatesan, I. Bhatnagar, P. Manivasagan, K. H. Kang
and S. K. Kim, Int. J. Biol. Macromol., 2015, 72, 269–281.
163 A. Blaeser, N. Million, D. F. D. Campos, L. Gamrad, M. Kopf,
C. Rehbock, M. Nachev, B. Sures, S. Barcikowski and
H. Fischer, Nano Res., 2016, 9, 3407–3427.
164 J. L. Davila and M. A. d’Avila, Int. J. Adv. Manuf. Technol.,
2019, 101, 675–686.
Review Journal of Materials Chemistry B
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
0 
A
ug
us
t 2
02
0.
 D
ow
nl
oa
de
d 
on
 8
/1
8/
20
20
 1
0:
24
:0
1 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
